The a2 Milk Company Limited logo

Retirement of director / appointment of new director

Director Appointment12 May 2019ATMConsumer Staples

NZX Code: ATM
ASX Code: A2M


The a2 Milk Company Limited

www.thea2milkcompany.com


13 May 2019

NZX/ASX Market Release


Retirement of independent non-executive director – Peter Hinton

Appointment of new independent non-executive director – Pip Greenwood


The a2 Milk Company Limited advises that Peter Hinton will be retiring from the Board at the end of the financial

year on 30 June, as foreshadowed at the Company’s 2018 Annual Meeting.


David Hearn, Chair of the Board, said of Peter’s retirement, “We would like to thank Peter for his exceptional and

longstanding commitment to the a2 Milk™ business, originally as advisor to and partner of Dr Corran McLachlan,

the Company’s founder, and subsequently as an adviser and director of the Company. We wish Peter all the best

as he pursues interests outside of The a2 Milk Company and corporate governance roles.”


The Company is pleased to advise that Pip Greenwood will be appointed as an independent non-executive

director of the Company with effect from 1 July 2019.


Pip is a director on the boards of Westpac New Zealand, Spark New Zealand and Fisher & Paykel Healthcare. She

was previously a senior partner at law firm Russell McVeagh, where she spent over ten years on the firm's board

including acting as the firm's board Chair and interim CEO. A leader in the field of corporate law and in the New

Zealand business community, Pip is also known for her work promoting greater diversity in the workplace. She is

the recipient of numerous industry awards including last year being named New Zealand Dealmaker of the Year at

the Australasian Law Awards 2018, the only person to have won this accolade five times, and has twice been

recognised as a finalist at the Women of Influence Awards.


David Hearn said of Pip’s appointment, “We are delighted to have a person of Pip’s considerable talent and

experience join the Board.”


The Board has determined that Ms Greenwood will be an independent director. A resolution to elect Ms

Greenwood will be put to shareholders at the Company’s next annual meeting in November 2019.



David Hearn

Chair

The a2 Milk Company Limited


For further information, please contact:

Investors / Analysts

David Akers

Head of Investor Relations

T +61 2 9697 7013 l M +61 412 944 577

david.akers@a2milk.com

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • NZX — NZX Limited: NZX board announces director appointment
    2019-06-25

    NZX Limited Level 1, NZX Centre 11 Cable Street PO Box 2959 Wellington 6140 New Zealand Tel +64 4 472 7599 www.nzx.com www.nzx.com 1 of 1 26 June 2019 NZX board announces director appointment The NZX board announces the appointment of John McMahon as a direct…”

  • AFT — AFT Pharmaceuticals Limited: Annual Meeting and Closing Date for Director Nominations
    2019-06-03

    AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN 609 017 969 Market Release 4 June 2019 Annual Meeting and Closing Date for Director Nominations AFT Pharmaceuticals Limited (NZX: AFT, A…”

  • GNZ — Goodman NZ: GMT Notice of Meeting
    2019-06-04

    E xplanator y notes Resolution 1: Re-appointment of Keith Smith Keith Smith retires by rotation at the meeting and offers himself for re-appointment. Keith is a professional director. He was previously a partner in the chartered accountancy practice of B…”